跳转至内容
Merck
  • Elemental diets may reduce the risk of aspiration pneumonia in bedridden gastrostomy-fed patients.

Elemental diets may reduce the risk of aspiration pneumonia in bedridden gastrostomy-fed patients.

The American journal of gastroenterology (2013-02-13)
Akira Horiuchi, Yoshiko Nakayama, Ryosei Sakai, Manabu Suzuki, Masashi Kajiyama, Naoki Tanaka
摘要

Our clinical experience suggested that elemental diets were associated with a reduction in aspiration pneumonia among bedridden patients with percutaneous endoscopic gastrostomy (PEG). We compared the effects of elemental and standard liquid diets on the risk of clinical aspiration pneumonia and gastric emptying in bedridden patients receiving PEG feedings. Study 1: consecutive bedridden PEG patients received elemental diets or standard liquid diets in the same fashion. The frequency of defecation, diet aspirated from the trachea, and aspiration pneumonia during hospitalization were prospectively recorded. Study 2: a randomized, crossover trial using elemental or standard liquid diets containing (13)C sodium acetate as a tracer given to bedridden PEG patients who had experienced aspiration pneumonia. (13)C breath tests were performed to estimate gastric emptying. Study 1: 127 patients were enrolled, 60 with elemental and 67 with standard liquid diets. The diet was aspirated from the trachea in none (0%) with the elemental diet vs. 8 (11.9%) with standard liquid diets (P=0.0057); aspiration pneumonia developed none with the elemental diet vs. 5 (7.5%) with standard liquid diets (P=0.031) (number needed to treat 14, 95% confidence interval 7-85). Study 2: 19 patients were enrolled. The elemental diet was associated with a significant increase in the 10, 30 or 50% emptying (excretion) time (P<0.001) and increased the area under the curve (% dose/h) compared with the standard liquid diet (P<0.05). Elemental diets were associated with more rapid gastric empting and fewer episodes of aspiration than standard liquid diets in bedridden PEG patients. They may be preferred for bedridden PEG patients especially who have experienced aspiration pneumonia. Properly performed randomized-controlled trials are needed to prove this potential benefit.

材料
货号
品牌
产品描述

Sigma-Aldrich
乙酸钠, anhydrous, ReagentPlus®, ≥99.0%
Sigma-Aldrich
乙酸钠 三水合物, ACS reagent, ≥99%
Sigma-Aldrich
乙酸钠, ACS reagent, ≥99.0%
Sigma-Aldrich
乙酸钠, puriss. p.a., ACS reagent, reag. Ph. Eur., anhydrous
Sigma-Aldrich
乙酸钠 三水合物, ReagentPlus®, ≥99.0%
Sigma-Aldrich
乙酸钠 三水合物, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E262, 99.0-101.0% (calc. to the dried substance), ≤0.00002% Al
Sigma-Aldrich
乙酸钠, 99.995% trace metals basis
Sigma-Aldrich
乙酸钠 溶液, BioUltra, for molecular biology, ~3 M in H2O
Sigma-Aldrich
乙酸钠, anhydrous, BioUltra, for luminescence, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
乙酸钠, powder, BioReagent, suitable for electrophoresis, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
乙酸钠, anhydrous, for molecular biology, ≥99%
Sigma-Aldrich
乙酸钠 三水合物, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
乙酸钠 三水合物, BioXtra, ≥99.0%
Sigma-Aldrich
乙酸钠 三水合物, meets USP testing specifications
Sigma-Aldrich
乙酸钠, BioXtra, ≥99.0%
Sigma-Aldrich
乙酸钠, meets USP testing specifications, anhydrous
Sigma-Aldrich
乙酸钠 三水合物, AR, 99-102%